Selected Publications and Resources Related to H3N2v
Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of the 2010-11 seasonal influenza vaccine on cross-reactive antibodies-United States. MMWR 2012;61(14):237-241.
Balish A, Garten R, Kilmov A,Villanueva J. Analytical detection of influenza A(H3N2)v and other A variant viruses from the USA by rapid influenza diagnostic tests. Influenza and Other Respiratory Viruses 2013; 7(4), 491-496.
Bowman A, Sreevatsa S, Killian M, et al. Molecular evidence for interspecies transmission of H3N2pM/H3N2v influenza A viruses at an Ohio agricultural fair, July 2012. Emerging Microbes and Infections 2012; 1, e33; doi:10.1038/emi.2012.33.[1.82 MB, 8 pages]
Cauchemez S, Eppereson S, Biggerstaff M, et al. Using Routine Surveillance Data to Estimate the Epidemic Potential of Emerging Zoonoses: Application to the Emergence of US Swine Origin Influenza A H3N2v Virus. PLoS Medicine 2013; 10(3): e1001399. doi:10.1371/journal.pmed.1001399.
Chen Q, Madson D, Miller CL, et al. Vaccine development for protecting swine against influenza virus. Vaccine development for protecting swine against influenza virus. Anim Health Res Rev 2012; 13(2):181-95. doi: 10.1017/S1466252312000175.
Feng Z, Gomez J, Bowman AS, et al. Antigenic Characterization of H3N2 Influenza A Viruses from Ohio Agricultural Fairs. J Virol 2013; 87(13):7655-67. doi: 10.1128/JVI.00804-13.
Houser KV, Katz JM, Tumpey Tm. Seasonal trivalent inactivated influenza vaccine does not protect against newly emerging variants of influenza A (H3N2v) virus in ferrets. J Virol. 2013 Jan; 87(2):1261-3. doi: 10.1128/JVI.02625-12. Epub 2012 Oct 31.
Jhung M, Epperson S, Biggerstaff M, et al. Outbreak of Variant Influenza A (H3N2v) Virus in the United States. Clinical Infectious Diseases 2013; doi: 10.1093/cid/cit649[756 KB, 30 pages].
Kitikoon P, Nelson M, Killian ML, et al. Genotype patterns of contemporary reassorted H3N2 virus in US swine. J Gen Virol 2013; 94(Pt 6):1236-41. doi: 10.1099/vir.0.51839-0.
Kitikoon P, Vincent Al, Gauger PC, etal. Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011. J Virol. 2012; Jun;86(12):6804-14. doi: 10.1128/JVI.00197-12.
Laskowski M, Duvvuri V, Buckeridge DL, et al. Influenza H3N2 variant viruses with pandemic potential: Preventing catastrophe in remote and isolated Canadian communities. Prev Med. 2013; doi: 10.1016/j.ypmed.2013.04.011.
Lindstrom S, Garten R, Balish A, et al. Human Infections with Novel Reassortant Influenza A(H3N2)v Viruses, United States, 2011. EID 2012; DOI: 10.3201/eid1805.111922.
MMWR: July 27, 2012: Notes from the Field: Outbreak of Influenza A (H3N2) Virus Among Persons and Swine at a County Fair — Indiana, July 2012. MMWR 2012; 61(29); 561.
MMWR, August 17, 2012: Evaluation of Rapid Influenza Diagnostic Tests for Influenza A (H3N2)v Virus and Updated Case Count — United States, 2012. MMWR 2012; 61(Early Release); 1-3.
Nelson M, Vincent Al, Kitikoon P, et al. Evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009-2011. J Virol. 2012; 86(16):8872-8. doi: 10.1128/JVI.00259-12.
Pearce M, Jayaraman A, Pappas C, et al. Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets. Proc Natl Acad Sci U.S.A 2012; 109(10):3944-9. doi: 10.1073/pnas.1119945109. Epub 2012 Feb 21.
Skowronski DM, et al. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). JID 2012; 206: 1852-6.
Skowronski DM, Moser F, Janjua N, et al. H3N2v and Other Influenza Epidemic Risk Based on Age-Specific Estimates of Sero-Protection and Contact Network Interactions. PLOS One 2013; 8(1): e54015. doi:10.1371/journal.pone.0054015.
Swerdlow D and Finelli L.Supplement: The Emergence of Influenza A (H3N2)v Virus: What we Learned From the First Wave, July 2011-April 2012. CID 2013; doi:10.1093/cid/cit325.
- Biggerstaff M, Reed C, Epperson S, et al. Supplement Article: Estimates Of the Number of Human Infections with Influenza A(H3N2) Variant Virus, United States, August 2011-April 2012. CID 2013; doi:10.1093/cid/cit273.
- Epperson S, Jhung M, Richards S, et al. Supplement Article: Human Infections with Influenza A(H3N2) Variant Virus in the United States, 2011-2012. CID 2013; doi:10.1093/cid/cit272.
- Gambhir M, Swerdlow D, Finelli L, et al. Supplement Article: Multiple Contributory Factors to the Age Distribution of Disease Cases: A Modeling Study in the Context of Influenza A(H3N2v). CID 2013; doi:10.1093/cid/cit29.
- Wong K, Gambhir M, Finelli L, et al. Supplement Article: Transmissibility of Variant Influenza From Swine to Humans: A Modeling Approach. CID 2013; doi:10.1093/cid/cit30.
Terebuh P, Olsen CW, Wright J, Kilmov A, et al. Transmission of influenza A viruses between pigs and people, Iowa, 2002-2004. Influenza Other Respi Viruses. 2010; Nov;4(6):387-96. doi: 10.1111/j.1750-2659.2010.00175.x.
Waalen K, Kilander A, Dudman S, et al. Age-dependent prevalence of antibodies cross-reactive to the influenza A (H3N2) variant virus in sera collected in Norway in 2011. Euro Surveillance 2012, 17(19): 1-5.
Wongphatcharachai M, Wang P, Enomoto S. Neutralizing DNA aptamers against swine influenza H3N2 viruses. J Clin Microbiol. 2013; Jan;51(1):46-54. doi: 10.1128/JCM.02118-12.
- Page last reviewed: September 27, 2013
- Page last updated: September 27, 2013
- Content source:
- Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)
- Page maintained by: Office of the Associate Director for Communication, Digital Media Branch, Division of Public Affairs